BioMarin Pharmaceutical (Nasdaq: BMRN) develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
Recent Mentions on Fool.com
- Will Suitors Line Up to Buy These Biotech Stocks Next?
- Hot Issues on BioMarin Pharmaceutical Inc. Earnings Conference Call
- 3 Things to Watch as BioMarin Pharmaceutical Inc. Reports Earnings
- Why 1 Wall Street Firm Thinks BioMarin Pharmaceutical Inc. Could Soar
- Healthcare Merger Monday: These 3 Stocks Could Be Healthcare's Next Buyout Targets